The ALDH2*2 polymorphism is associated with CAD susceptibility [15], and the mechanism of this effect is partially explained by decreased DDAH1 expression and increased ADMA levels in endothelial cells. This evidence concerns the gene DDAH1 and coronary artery disorder.